LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC) common stock pursuant and/or traceable to the Company’s October 2024 initial public offering (the “IPO”). IF YOU SUFFERED A LOSS ON YOUR KINDERCARE INVESTMENTS, CLICK HERE TO INQU ...

LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) securities between March 7, 2024 and May 23, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR SAVARA INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOU ...

LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR CYTOKINETICS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIAL ...

LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR LANTHEUS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUIN ...

Core Viewpoint - WORK Medical Technology Group LTD has announced a registered direct offering of 38,999,334 Class A ordinary shares at a price of $0.075 per share, aiming to raise approximately $2.9 million in gross proceeds [1][2]. Group 1: Offering Details - The offering involves the sale of Class A ordinary shares or pre-funded warrants at a purchase price of $0.075 per share, with the pre-funded warrants having an exercise price of $0.0005 per share [1]. - The transaction is expected to close on or about September 26, 2025, pending customary closing conditions [2]. - The offering is made under a shelf registration statement on Form F-3, which was declared effective by the SEC on September 15, 2025 [3]. Group 2: Company Overview - WORK Medical Technology Group LTD, through its subsidiary, develops and manufactures Class I and II medical devices, with a diverse product portfolio of 21 products, including customized masks and medical consumables [5]. - The company has sold products in 34 provincial-level regions in China and has 15 products available in over 30 countries globally [5]. - WORK Medical has received various quality-related manufacturing designations and has registered 17 products with the U.S. FDA, allowing entry into the U.S. market [5].

LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 18, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Quanex Building Products Corporation (“Quanex” or the “Company”) (NYSE: NX) securities between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR QUANEX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY ...

NEW ORLEANS, Sept. 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquired the Company’s securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of ...

New York, NY, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PhoneX Holdings, Inc. (the "Company") (OTC Pink: PXHI), has confirmed that FINRA has established October 2, 2025 as the ex-dividend date. About PhoneX Holdings, Inc. PhoneX Holdings, Inc. is a technology company powering the global wholesale trade of pre-owned mobile devices. Its industry-leading SaaS platform helps carriers, manufacturers, and distributors manage inventory, optimize sales, and grow their customer networks. By driving efficiency, transparency ...

New York, NY, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PhoneX Holdings, Inc. (the "Company") (OTC Pink: PXHI), has confirmed that FINRA has established October 2, 2025 as the ex-dividend date. About PhoneX Holdings, Inc. PhoneX Holdings, Inc. is a technology company powering the global wholesale trade of pre-owned mobile devices. Its industry-leading SaaS platform helps carriers, manufacturers, and distributors manage inventory, optimize sales, and grow their customer networks. By driving efficiency, transparency ...

2025 年第五次全球扩张加速 eXp 亚太势头和“经纪人优先”运动华盛顿州贝灵汉, Sept. 26, 2025 (GLOBE NEWSWIRE) -- 全球最大的独立房地产经纪公司 eXp Realty®，也是 eXp World Holdings, Inc. (Nasdaq：EXPI) 的核心子公司，今日宣布正式进入韩国市场，这是其在 2025 年拓展的第五个国际市场，也是今年继日本之后在亚洲进入的第二个市场。 此次扩张建立在秘鲁、土耳其、厄瓜多尔和日本快速增长的经纪人主导势头之上。 在韩国，传统经纪公司仍依赖固定办公室和僵化等级制度，eXp 则推出了一家本质上不同的平台：AI 原生、无边界，旨在为经纪人提供更多对其未来的自由、灵活性和控制权。 eXp Realty 国际董事总经理 Felix Bravo 表示：“韩国大多数经纪公司仍在沿用陈旧模式，它为老板服务，而非为经纪人设计。 这种模式的成效与其目的吻合：控制经纪人、限制上升空间、维护等级制度。 经纪人在手机端推进国际业务、创下真实业绩，却仍受困于办公室指标和陈旧规则。 这种体系无法修补， 只能替换。 我们来此的目的并非与其竞争，而是要终结这种模式 ...